28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss.

      Proceedings of the National Academy of Sciences of the United States of America
      Animals, Blood Glucose, drug effects, metabolism, Bone Marrow Cells, physiology, Bone Marrow Transplantation, Cell Cycle Proteins, DNA-Binding Proteins, Diabetes Mellitus, genetics, pathology, therapy, E2F Transcription Factors, E2F1 Transcription Factor, Female, Insulin, therapeutic use, Islets of Langerhans, Male, Mice, Mice, Knockout, Polyploidy, Sex Characteristics, Transcription Factors, deficiency, Transplantation, Homologous

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Our studies of mice deficient for the E2F1 and E2F2 transcription factors have revealed essential roles for these proteins in the cell cycle control of pancreatic exocrine cells and the regulation of pancreatic beta cell maintenance. Pancreatic exocrine cells in E2f1-/-E2f2 mutant mice become increasingly polyploid with age, coinciding with severe exocrine atrophy. Furthermore, mice deficient for both E2F1 and E2F2 develop nonautoimmune, insulin-dependent diabetes with high penetrance. Surprisingly, transplantation of wild-type bone marrow can prevent or rescue diabetes in E2f1-/-E2f2-/-mice. We hypothesize that exocrine degeneration results in a destructive environment for beta cells, which can be alleviated by restoration of the hematopoietic system that is also defective in E2f1-/-E2f2-/-mice The demonstration that beta cell maintenance under conditions of stress is influenced by bone marrow-derived cells may provide important insight into the design of therapies to boost islet mass and function in diabetic patients.

          Related collections

          Author and article information

          Comments

          Comment on this article